Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the deadliest tumors. The majority of HCC is detected in the late stage, and the clinical results for HCC patients are poor. There is an urgent need to discover early diagnostic biomarkers and potential therapeutic targets for HCC. METHODS: The GS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qingqing, Yu, Xiaoyan, Zheng, Zhewen, Chen, Fengxia, Yang, Ningning, Zhou, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2021
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101454/
https://www.ncbi.nlm.nih.gov/pubmed/33987018
http://dx.doi.org/10.7717/peerj.11342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8101454/
https://www.ncbi.nlm.nih.gov/pubmed/33987018
http://dx.doi.org/10.7717/peerj.11342

Ejemplares similares